The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567).

These Regulations amend the Veterinary Medicines Regulations 2013 (S.I. 2013/2033) in several sections; the manufacture of veterinary medicinal products (regulation 5); the prohibition of supply of veterinary medicinal products after their expiry date (regulation 6); advertising and promotion of veterinary medicinal products (regulations 7 to 9); exemptions from the scope of the 2013 Regulations (regulation 10); record-keeping requirements (regulations 11 to 15); imports of unauthorised veterinary medicinal products (regulation 16); appeals (regulation 17); exports (regulation 18); time limits (regulation 19); enforcement (regulations 20 to 25). Part 3 amends Schedule 1 to the 2013 Regulations, which governs applications for marketing authorisations in respect of veterinary medicinal products; paragraph 24 now includes among the reason for refusing the marketing authorization that the veterinary medicinal product is a veterinary medicinal product which contains an antimicrobial which is presented for use in order to promote the growth of treated animals or to increase yields from treated animals. Part 4 amends Schedule 2 to the 2013 Regulations, which governs the manufacture of veterinary medicinal products. Regulation 92 inserts new Part 2 to that Schedule, concerning the authorisation of autogenous vaccines, blood-banks, stem cell centres and products manufactured under the cascade. Regulation 93 inserts new Part 2A (regulating active substances) and Part 2B (offences) to that Schedule. Part 5 amends Schedule 3 to the 2013 Regulations, which governs classification and supply of veterinary medicines, wholesale dealers and sheep dip. Part 7 amends Schedule 5 to the 2013 Regulations, which governs medicated feedingstuffs and specified feed additives. Part 9 amends Schedule 7 to the 2013 Regulations, which sets out fees in respect of the 2013 Regulations.